O'Grady Brendan P.
Transaction: 07/27/2026
OTHER
Change
0
Price
Not reported
Filing
07/31/2026
Type
OTHER
Nasus Pharma Ltd.
NSRX • Medical - Pharmaceuticals
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 54%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$31.44M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$31.44M
52W Range1.98 - 9.99
Beta3.96
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.00
Quick Ratio0.00
Target$22.00
Price$0.00
Change0.00%
Market Cap$31.44M
52W Range1.98 - 9.99
Beta3.96
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.00
Quick Ratio0.00
Target$22.00
Target Median$22.00
Target Range22.00 - 22.00
Volume18.23K
Avg Volume35.81K
EPS Surprise-0.27
Investment DNA
How strong this company looks for long-term investors
25
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-19
Low
$22.00
Mean
$22.00
Median
$22.00
High
$22.00
Insider Transactions
Recent executive and insider activity
Teleman Dan Benjamin
Transaction: 07/22/2026
OTHER
Change
0
Price
Not reported
Filing
07/29/2026
Type
OTHER
Teleman Dan Benjamin
Transaction: 06/17/2026
BUY
Change
+6,550
Price
$3.10
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| O'Grady Brendan P. | OTHER | 0 | Not reported | 07/27/2026 | 07/31/2026 |
| Teleman Dan Benjamin | OTHER | 0 | Not reported | 07/22/2026 | 07/29/2026 |
| Teleman Dan Benjamin | BUY | +6,550 | $3.10 | 06/17/2026 | 06/22/2026 |
| Teleman Dan Benjamin | BUY | +2,900 | $3.76 | 04/22/2026 | 04/22/2026 |
| Teleman Dan Benjamin | BUY | +15,000 | $2.04 | 03/31/2026 | 04/01/2026 |
| Rubin Eyal | OTHER | +40,549 | $7.56 | 11/20/2026 | 03/27/2026 |
| Megiddo Dalia | OTHER | 0 | Not reported | 03/18/2026 | 03/27/2026 |
| Hershman Ronnie | OTHER | 0 | Not reported | 03/18/2026 | 03/27/2026 |
| Gilboa Udi | OTHER | 0 | Not reported | 03/18/2026 | 03/27/2026 |
| Teleman Dan Benjamin | OTHER | 0 | Not reported | 03/18/2026 | 03/27/2026 |
| Israel Isaac | OTHER | +10,000 | $5.38 | 03/11/2026 | 03/27/2026 |
| Shacham Sharon | OTHER | +10,000 | $5.38 | 03/11/2026 | 03/27/2026 |
| Silberman David | OTHER | +10,000 | $5.38 | 03/11/2026 | 03/27/2026 |
| Hershman Ronnie | OTHER | +17,970 | $6.53 | 02/13/2026 | 03/27/2026 |
| Gilboa Udi | OTHER | +17,970 | $6.53 | 02/13/2026 | 03/27/2026 |
| Teleman Dan Benjamin | OTHER | +318,856 | $6.05 | 01/07/2026 | 03/27/2026 |
| Hershman Ronnie | OTHER | +63,017 | $4.30 | 05/06/2020 | 03/27/2026 |